Cottonwood Capital Advisors LLC Grows Stake in Zoetis Inc. (NYSE:ZTS)

Cottonwood Capital Advisors LLC raised its position in shares of Zoetis Inc. (NYSE:ZTS) by 24.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,278 shares of the company’s stock after buying an additional 247 shares during the quarter. Cottonwood Capital Advisors LLC’s holdings in Zoetis were worth $208,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new position in Zoetis during the 3rd quarter valued at approximately $31,000. First Personal Financial Services purchased a new position in Zoetis during the 3rd quarter valued at approximately $33,000. Capital Performance Advisors LLP purchased a new position in Zoetis during the 3rd quarter valued at approximately $33,000. Dunhill Financial LLC lifted its stake in shares of Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after purchasing an additional 75 shares during the last quarter. Finally, Quarry LP lifted its stake in shares of Zoetis by 273.2% in the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after purchasing an additional 153 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ZTS. UBS Group began coverage on Zoetis in a research note on Monday, December 9th. They issued a “neutral” rating and a $196.00 price objective for the company. Stifel Nicolaus lowered their price objective on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. raised their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Finally, Leerink Partners began coverage on Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective for the company. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Zoetis currently has an average rating of “Buy” and a consensus target price of $211.89.

Zoetis Trading Up 1.0 %

Shares of NYSE ZTS opened at $168.63 on Friday. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The business has a fifty day simple moving average of $170.23 and a two-hundred day simple moving average of $179.71. The firm has a market cap of $76.08 billion, a PE ratio of 31.70, a price-to-earnings-growth ratio of 2.57 and a beta of 0.89. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53.

Zoetis (NYSE:ZTS) last issued its earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.36 EPS. Analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 dividend on an annualized basis and a yield of 1.19%. Zoetis’s payout ratio is 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.